Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ: AVIR · Real-Time Price · USD

4.730

+0.180 (3.96%)

At close: May 28, 2026, 4:00 PM EDT

4.730

0.00 (0.00%)

After-hours: May 28, 2026, 4:10 PM EDT

Atea Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	379	279	283	254	401	743
Market Cap Growth	49.43%	-1.43%	11.19%	-36.48%	-46.08%	-78.43%
Enterprise Value	122.36	-22.92	-170.93	-321.99	-243.69	-21.44
Last Close Price	4.73	3.57	3.35	3.05	4.81	8.94
PE Ratio	-	-	-	-	-	6.53
PS Ratio	-	-	-	-	-	2.11
PB Ratio	1.56	0.35	0.35	0.46	0.63	1.05
P/TBV Ratio	0.47	0.37	0.35	0.46	0.63	1.11
EV/Sales Ratio	-	-	-	-	-	-0.06
EV/EBITDA Ratio	-	0.13	0.89	1.97	1.87	-
EV/EBIT Ratio	-	0.13	0.89	1.96	1.87	-
EV/FCF Ratio	-	0.17	1.26	3.77	1.98	0.25
Debt / Equity Ratio	-	0	0.00	0.00	0.00	0
Debt / EBITDA Ratio	-	-	-	-	-	0.00
Net Debt / Equity Ratio	-0.32	-0.38	-0.56	-1.04	-1.00	-1.08
Net Debt / EBITDA Ratio	1.35	1.67	2.35	3.52	4.94	-5.52
Net Debt / FCF Ratio	1.73	2.28	3.34	6.74	5.24	8.78
Asset Turnover	-	0	0	0	0	0.43
Quick Ratio	7.67	7.59	24.44	17.86	35.00	13.44
Current Ratio	7.89	7.82	24.85	18.24	35.77	13.58
Return on Equity (ROE)	-21.19%	-19.78%	-24.79%	-22.74%	-17.16%	19.27%
Return on Assets (ROA)	-62.87%	-44.65%	-36.62%	-26.22%	-17.61%	14.79%
Return on Invested Capital (ROIC)	775.31%	1042.30%	1716.19%	2643.87%	551.85%	-493.07%
Return on Capital Employed (ROCE)	-74.58%	-50.14%	-38.26%	-27.12%	-19.15%	21.90%
Earnings Yield	-	-	-	-	-	15.32%
Buyback Yield / Dilution	5.40%	3.29%	-1.05%	-0.17%	5.67%	-308.70%
Total Shareholder Return	5.40%	3.29%	-1.05%	-0.17%	5.67%	-308.70%

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q